Literature DB >> 3712276

Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart.

A M Gillis, R E Kates.   

Abstract

The myocardial disposition of propafenone was studied in an isolated perfused rabbit heart. Six hearts were perfused with a modified Krebs-Henseleit buffer containing propafenone 110 +/- 5 ng/ml. Pharmacokinetic parameters were determined by fitting the coronary sinus effluent propafenone concentration-time data to a one-compartment pharmacokinetic model. The mean half-life of myocardial uptake (T1/2d) was 22.3 +/- 5.9 min and the average time to approach steady-state tissue levels was 112 +/- 29 min. Propafenone accumulated extensively in myocardium and at equilibrium the average (+/- S.D.) myocardial concentration was 114 +/- 21 times that of the perfusate. The electrophysiological effect was measured as percentage of change of the baseline QRS duration. The half-life of onset of effect (T1/2e) and the effect at steady state were determined by fitting the effect-time data to a monoexponential function. The T 1/2e averaged 26.0 +/- 9.4 min and did not differ significantly from T 1/2d. The relationship between myocardial propafenone concentration and effect was linear but there was interexperimental variability in the slopes of the lines of this concentration-effect relationship. The interexperimental differences in steady-state effect could not be accounted for by differences in myocardial concentration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3712276

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Ryanodine receptor inhibition potentiates the activity of Na channel blockers against spontaneous calcium elevations and delayed afterdepolarizations in Langendorff-perfused rabbit ventricles.

Authors:  Young Soo Lee; Mitsunori Maruyama; Po Cheng Chang; Hyung Wook Park; Kyoung-Suk Rhee; Yu-Cheng Hsieh; Chia-Hsiang Hsueh; Changyu Shen; Shien-Fong Lin; Hyun Seok Hwang; Huiyong Yin; Björn C Knollmann; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

2.  Effect of plasma protein binding on kinetics of capillary uptake and efflux.

Authors:  D J Morgan; J L Huang
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

3.  Myocardial uptake of lignocaine: pharmacokinetics and pharmacodynamics in the isolated perfused heart of the rabbit.

Authors:  J X Mazoit; J P Kantelip; E E Orhant; J M Talmant
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

4.  Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.

Authors:  A Capucci; G Boriani; B Marchesini; E Strocchi; L Tomasi; M Balducelli; L Frabetti; E Ambrosioni; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 5.  Guidelines for the use of propafenone in treating supraventricular arrhythmias.

Authors:  A G Kishore; A J Camm
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of propafenone.

Authors:  J T Hii; H J Duff; E D Burgess
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

Review 7.  Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.

Authors:  A Capucci; G Boriani
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.